Furthermore, the multiplex cytotoxicity assay is also useful for evaluating CD8+ T cell cytotoxicity responses in T cell therapies such as those involving chimeric antigen receptor (CAR)-T cells or cancer vaccines. Here, CD8A is linked to cancer.